Catalog #TR60
Tirzepatide
60 MG
Select Size:
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$140.00
Technical Research Description
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It contains a C20 fatty diacid moiety enabling extended duration of action. The molecule demonstrates 5:1 GIP:GLP-1 receptor binding affinity ratio, providing unique dual-pathway activation in metabolic research.
Simplified Explanation
This is a "twincretin" compound that activates two different hormone receptors at once - GIP and GLP-1. Unlike single-target peptides, it can trigger multiple metabolic pathways simultaneously. Scientists study how this dual-action affects cellular metabolism differently than activating just one pathway.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
Frequently bought together
From Our Research Blog
Background reading and laboratory context for Tirzepatide 60 MG — sourced from our research articles.
research
Tirzepatide in Metabolic Research: Dual Agonism
A research-focused look at tirzepatide's dual GIP/GLP-1 receptor agonism, experimental design considerations, and common comparato…
Aug 24, 2026
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
research
Tirzepatide: perspectivas mecanísticas en investigación metabólica preclínica
Resumen científico de tirzepatide como agonista dual GIP/GLP-1 en investigación metabólica. Mecanismos, biomarcadores y diseño exp…
Jun 10, 2026
research
Tirzepatide Research Spotlight: Dual Incretin Signaling Mechanisms
Explore tirzepatide research on dual GIP/GLP-1 receptor signaling, metabolic pathways, and experimental design considerations for …
Jun 10, 2026
research
B-12 and Metabolic Research: Beyond the Energy Hype
A research-focused look at B-12 biology: one-carbon metabolism, mitochondria, biomarkers, and how study design shapes what you can…
Sep 4, 2026
research
AOD-9604 in preclinical metabolism research: what we know
AOD-9604 is a GH-fragment research peptide studied for lipid handling and metabolic signaling. Here's what preclinical data sugges…
Sep 4, 2026